Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A low-grade glioma that occurs in children and encompasses tumors of astrocytic, oligodendroglial, and mixed glial-neuronal histology.
Biomarker and diagnostic research for childhood low-grade glioma has been reported in the published literature.
No clinical trials have been registered for childhood low-grade glioma.
8 publications have been identified in PubMed for childhood low-grade glioma. Research spans Other (25%), Epidemiology / Natural History (25%), and Diagnostic / Biomarker (13%).
Jung Y (2025). [PMID: 40658996](https://pubmed.ncbi.nlm.nih.gov/40658996/). *Journal of neurosurgery. Case lessons*. [Case Report / Case Series]
Bruckert L (2025). [PMID: 40270760](https://pubmed.ncbi.nlm.nih.gov/40270760/). *Frontiers in neuroscience*. [Epidemiology / Natural History]
Mwachaka PM (2025). [PMID: 41293442](https://pubmed.ncbi.nlm.nih.gov/41293442/). *Neuro-oncology pediatrics*. [Review / Meta-Analysis]
Papusha L (2024). [PMID: 38976815](https://pubmed.ncbi.nlm.nih.gov/38976815/). *JCO precision oncology*. [Gene Therapy / Novel Therapeutics]
Boop S (2024). [PMID: 38676718](https://pubmed.ncbi.nlm.nih.gov/38676718/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Epidemiology / Natural History]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 6:52 AM UTC
Gorodezki D (2024). [PMID: 38580878](https://pubmed.ncbi.nlm.nih.gov/38580878/). *Journal of cancer research and clinical oncology*. [Diagnostic / Biomarker]
de Bont JM (2024). [PMID: 39400717](https://pubmed.ncbi.nlm.nih.gov/39400717/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Other]
van Roessel IMAA (2024). [PMID: 39140359](https://pubmed.ncbi.nlm.nih.gov/39140359/). *Endocrine connections*. [Other]
AI-curated news mentioning childhood low-grade glioma
Updated Mar 11, 2026
A recent study evaluates the cost-effectiveness of dabrafenib and trametinib for treating pediatric patients with BRAF V600E mutation low-grade glioma in England and Wales. This research could influence treatment decisions and healthcare resource allocation for this patient population.
A Delphi consensus has established recommendations for managing adverse events in pediatric low-grade glioma patients undergoing MAPK-directed therapies. This highlights the need for improved strategies to address these challenges in treatment.